Category: <span>Chemotherapy/Chemo drugs</span>

FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma

The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination.  The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]

The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma

The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination.  The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]

The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone

Results of a new phase 3 clinical trial published in the Journal of Clinical Oncology indicate that a chemoimmunotherapy regimen combining chemotherapy with immunotherapy drugs improves patient survival more than chemotherapy alone for pleural mesothelioma. Study researchers used pembrolizumab (Keytruda) alongside platinum and pemetrexed chemotherapy. Christina S. Baik, MD, MPH, reviewed the phase 3 trial […]

The post Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.